Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline vs Nicotine Patch for Smoking Cessation
NCT02162849Phase 4Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2015
- Primary completion
- Feb 2028
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline, nicotine patch in Tobacco Use Disorder (TUD), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2015; status: active, not recruiting.
02
Drugs
vareniclinenicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02162849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162849.